Glycan Arrays Using Linkers for Reliable Immobilization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The development of glycan microarrays has been hindered by the difficulty in reliably immobilizing chemically and structurally diverse glycans, and glycans are not readily amenable to analysis using current molecular techniques, limiting their application in glycomics and cancer diagnosis.

Innovation Solution

The use of linkers that facilitate the attachment of glycans, such as Globo H, SSEA-3, SSEA-4, and other tumor-associated carbohydrate antigens, to substrates, enabling the creation of glycan arrays for efficient detection and binding analysis, and the use of these arrays for identifying carbohydrate binding partners and monitoring cancer.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If glycans are immobilized on substrates to create microarrays, then glycan interactions can be detected and analyzed, but the chemical and structural diversity of glycans makes reliable immobilization difficult

Engineering Contradiction:
Improvereliable immobilizationVSAvoidchemical and structural diversity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent employs linkers as intermediary molecules that facilitate the attachment of diverse glycans to the substrate. These linkers serve as a universal interface that can accommodate various glycan structures without requiring unique immobilization methods for each glycan type, thereby resolving the contradiction between reliable immobilization and chemical/structural diversity.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent develops a universal platform using standardized linkers that can immobilize multiple types of glycans with different chemical and structural properties. This universal approach allows the same substrate and linker system to handle diverse glycans, eliminating the need for glycan-specific immobilization protocols and enabling reliable microarray creation despite structural variability.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Adaptability or versatility

If current molecular techniques are used to analyze glycans, then analysis can be performed, but glycans are not readily amenable to these techniques limiting their application

Engineering Contradiction:
Improveapplication in glycomics and cancer diagnosisVSAvoidamenable to analysis
Core Design Contradiction:
Adaptability or versatilityVSDifficulty of detecting and measuring

Solution Approach 1:

The microarray platform acts as an intermediary system that makes glycans accessible to standard molecular techniques. By immobilizing glycans on a stable substrate with controlled orientation and density, the platform enables conventional detection and analysis methods to be applied to glycans, which would otherwise be difficult to analyze due to their structural complexity and lack of amplification capabilities.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If glycan arrays are created for detection and analysis, then sensitive detection of glycan interactions is achieved, but the complexity of glycan libraries and lack of well-defined structures remain obstacles

Engineering Contradiction:
Improvesensitive detectionVSAvoidcomplexity of glycan libraries
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the complex task of glycan analysis into manageable components by organizing diverse glycans into discrete, spatially separated locations on the microarray substrate. Each glycan or glycan class is positioned at specific array elements, allowing individual characterization while maintaining the ability to screen large libraries systematically, thereby reducing the perceived complexity through structured organization.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS10935544B2Glycan arrays and method of use
Publication Date: 2021.03.02 OBI PHARMA INC
  • US10935544B2 patent drawing
  • US10935544B2 patent drawing
  • US10935544B2 patent drawing

AI summary

The invention relates to linkers and methods for generating arrays with linkers. The invention also relates to methods for identifying agents that bind to various types of molecules on the arrays and to defining the structural elements of the molecules on the arrays that bind to those agents. The arrays and methods provided herein may be used for epitope identification, drug discovery and as analytical tools. The invention provides useful glycans and epitope determinants that are useful in detecting, diagnosing, recurrence monitoring and preventing cancer.